Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Evaluation of characteristics and prognostic factors of early progressive disease in newly diagnosed myeloma (<18 months) finds higher median age, β2, LDH, stage, more ultra-high risk disease and lower hemoglobin and eGFR.”
Authors: Eirini Katodritou et al.
More posts featuring Robert Orlowski.
